National Institute on Drug Abuse | Community Health

The National Institute on Drug Abuse (NIDA) is a United States federal government research institute dedicated to advancing our understanding of the causes and consequences of drug use and addiction. With a mission to improve individual and public health, NIDA has conducted extensive research on the biological, behavioral, and social components of addiction, supporting treatments like nicotine patches and gums, and investigating drug-related diseases such as AIDS. As a leading authority on drug abuse, NIDA's work has far-reaching implications for public health policy, treatment, and prevention. With a budget of over $1.4 billion in 2022, NIDA funds research across the United States, collaborating with institutions like the [[national-institutes-of-health|National Institutes of Health]] (NIH) and the [[centers-for-disease-control-and-prevention|Centers for Disease Control and Prevention]] (CDC). NIDA's research has led to significant advancements in our understanding of addiction, including the development of medications like [[buprenorphine|buprenorphine]] and [[methadone|methadone]] for opioid use disorder. However, the institute's monopoly on the supply of research-grade [[marijuana|marijuana]] has been a subject of controversy, with some arguing it hinders research on the potential therapeutic benefits of the substance.